Fujii Naohiko
Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine University of Pennsylvania, USA.
Clin Calcium. 2014 Dec;24(12):1853-9.
Chronic kidney disease - mineral and bone disorder (CKD-MBD) in kidney transplant recipients has a complex pathophysiology, which is a combination of carryover of mineral and bone disorder during the dialysis period and dynamic change in bone and mineral metabolism after transplantation. The most important thing is to know that this pathophysiology is a continuum from the early stage of CKD through the dialysis period to the post-transplant period. However, the current treatment approaches among Japanese nephrologists are based on three different categories : nephrologists elaborately treating predialysis patients against end-stage renal disease ; dialysis doctors aggressively coping with their patients' deadly complications ; and transplant doctors concentrating on post-transplant follow-ups for better graft survival. In this article, I would like to explain the pathophysiology of post-transplant CKD-MBD and then to introduce a new role -- that not only transplant doctors, but also dialysis doctors, should play a crucial role in CKD-MBD in the post-transplant period.
肾移植受者的慢性肾脏病 - 矿物质和骨代谢紊乱(CKD-MBD)具有复杂的病理生理学,它是透析期矿物质和骨代谢紊乱的延续与移植后骨和矿物质代谢动态变化的结合。最重要的是要明白,这种病理生理学是一个从CKD早期到透析期再到移植后期的连续过程。然而,目前日本肾脏病医生的治疗方法基于三个不同类别:肾脏病医生精心治疗终末期肾病的透析前患者;透析医生积极应对患者的致命并发症;移植医生专注于移植后的随访以提高移植物存活率。在本文中,我将解释移植后CKD-MBD的病理生理学,然后介绍一个新的角色——不仅移植医生,而且透析医生,都应在移植后阶段的CKD-MBD中发挥关键作用。